
Office of Communications
and Public Liaison (OCPL)
Building 31, Room 5C27
31 Center Drive, MSC 2292
Bethesda, MD 20892
Phone: 301-496-1752
nianews3@mail.nih.gov
NIA is the lead Federal agency for supporting and conducting Alzheimer's disease research. For NIA background information on this topic see:
See NIA research news related to Alzheimer's disease below.
Deposits of a hormone called amylin in the brain may indicate risk for developing dementia and type 2 diabetes, according to a study published online in the Annals of Neurology. The analysis by researchers at the NIA-funded Alzheimer...
Cognitively normal older adults with evidence of early brain changes typical of Alzheimer’s disease fell more often than did their peers without these brain changes, a new study reported online in Neurology. The results suggest that...
U.S. Department of Health and Human Services today released the National Plan to Address Alzheimer’s Disease: 2013 Update, a follow-up to the initial plan released in May 2012. The update reflects our national progress towards...
The costs of caring for people with dementia in the United States in 2010 were between $159 billion to $215 billion, and those costs could rise dramatically with the increase in the numbers of older people in coming decades, according to...
With new research funding from the National Institutes of Health, the nation’s premier Alzheimer’s disease study network will undertake four major studies aimed at finding new treatments for the disease. The award supports the...
NIH, Alzheimer’s Association invite research funders to participate A new, publicly available database is seeking to capture the full spectrum of current Alzheimer’s disease research investments and resources—both in...
Researchers investigating a known gene risk factor for Alzheimer’s disease discovered it is associated with lower levels of beta amyloid—a brain protein involved in Alzheimer’s—in cognitively healthy older people....
The Alzheimer’s Disease Research Summit 2012: Path to Treatment and Prevention, held May 14-15, 2012, brought together leading experts on Alzheimer’s disease and other complex diseases to identify research priorities and...
The hippocampus, a brain region important to learning and memory, gradually loses volume as part of the normal aging process. This loss is significantly accelerated in older people with Alzheimer’s disease, especially if they have...
Plaques made up of abnormal deposits of beta-amyloid protein are a hallmark of Alzheimer’s disease. The toxic buildup begins when the beta-secretase enzyme (BACE), working in concert with a partner enzyme, snips a small fragment of...